Paolo Cossu-Rocca

Summary

Country: Italy

Publications

  1. ncbi S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma
    Paolo Cossu-Rocca
    Department of Pathology, University of Sassari, Via G Matteotti 58, Sassari, Italy
    Am J Surg Pathol 33:1031-6. 2009
  2. ncbi Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis
    Paolo Cossu-Rocca
    Departments of Clinical and Experimental Medicine, Biomedical Sciences, University of Sassari, Sassari, Italy
    Int J Gynecol Pathol 31:570-9. 2012
  3. ncbi Evaluation of methylation degree from formalin-fixed paraffin-embedded DNA extract by field-amplified sample injection capillary electrophoresis with UV detection
    Angelo Zinellu
    Porto Conte Ricerche Srl, Tramariglio, 07041 Alghero, Sassari, Italy
    Anal Bioanal Chem 399:1181-6. 2011
  4. ncbi Role of molecular markers in diagnosis and prognosis of renal cell carcinoma
    Guido Martignoni
    Department of Pathology, University of Verona, Verona, Italy
    Anal Quant Cytol Histol 29:41-9. 2007
  5. ncbi Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma
    Matteo Brunelli
    Department of Pathology, University of Verona, Verona, Italy
    Anal Quant Cytol Histol 31:401-9. 2009
  6. ncbi CD10 is expressed in a subset of chromophobe renal cell carcinomas
    Guido Martignoni
    Anatomia Patologica, Universita di Sassari, Sassari, Italy
    Mod Pathol 17:1455-63. 2004
  7. ncbi High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples
    Maria Rosaria De Miglio
    Department of Biomedical Sciences, University of Sassari, Sassari, Italy
    Diagn Mol Pathol 19:201-8. 2010
  8. ncbi Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma
    Matteo Brunelli
    Department of Pathology, University of Verona, Verona, Italy
    Mod Pathol 21:1-6. 2008

Collaborators

Detail Information

Publications8

  1. ncbi S-100A1 is a reliable marker in distinguishing nephrogenic adenoma from prostatic adenocarcinoma
    Paolo Cossu-Rocca
    Department of Pathology, University of Sassari, Via G Matteotti 58, Sassari, Italy
    Am J Surg Pathol 33:1031-6. 2009
    ....
  2. ncbi Tyrosine kinase receptor status in endometrial stromal sarcoma: an immunohistochemical and genetic-molecular analysis
    Paolo Cossu-Rocca
    Departments of Clinical and Experimental Medicine, Biomedical Sciences, University of Sassari, Sassari, Italy
    Int J Gynecol Pathol 31:570-9. 2012
    ..Specific post-translational abnormalities, responsible for activation of TKRs, should be further investigated...
  3. ncbi Evaluation of methylation degree from formalin-fixed paraffin-embedded DNA extract by field-amplified sample injection capillary electrophoresis with UV detection
    Angelo Zinellu
    Porto Conte Ricerche Srl, Tramariglio, 07041 Alghero, Sassari, Italy
    Anal Bioanal Chem 399:1181-6. 2011
    ..0 and 3.2%, respectively. Because of its high accuracy and throughput, our method will be useful for large-scale applications to determine the implications of genomic DNA methylation levels in tumorigenesis...
  4. ncbi Role of molecular markers in diagnosis and prognosis of renal cell carcinoma
    Guido Martignoni
    Department of Pathology, University of Verona, Verona, Italy
    Anal Quant Cytol Histol 29:41-9. 2007
    ..A wide variety of molecular markers have been examined, but further research is required to prove their value as prognostic tools...
  5. ncbi Utility of tissue microarrays for assessment of chromosomal abnormalities in chromophobe renal cell carcinoma
    Matteo Brunelli
    Department of Pathology, University of Verona, Verona, Italy
    Anal Quant Cytol Histol 31:401-9. 2009
    ..To compare the results of numerical chromosomal changes in chromophobe renal cell carcinoma obtained from whole tissue sections with those of tissue microarrays...
  6. ncbi CD10 is expressed in a subset of chromophobe renal cell carcinomas
    Guido Martignoni
    Anatomia Patologica, Universita di Sassari, Sassari, Italy
    Mod Pathol 17:1455-63. 2004
    ..04). Parvalbumin was strongly expressed in all primary and metastatic chromophobe renal cell carcinomas. Western blot analysis was utilized to confirm the expression of both CD10 and parvalbumin in chromophobe renal cell carcinomas...
  7. ncbi High sensitivity of reverse-hybridization methodology in the detection of KRAS mutations from formalin-fixed paraffin-embedded colorectal cancer samples
    Maria Rosaria De Miglio
    Department of Biomedical Sciences, University of Sassari, Sassari, Italy
    Diagn Mol Pathol 19:201-8. 2010
    ..In our experience, reverse-hybridization technique has been shown to be an effective and more sensitive assay for the identification of the most common KRAS mutations...
  8. ncbi Loss of chromosome 9p is an independent prognostic factor in patients with clear cell renal cell carcinoma
    Matteo Brunelli
    Department of Pathology, University of Verona, Verona, Italy
    Mod Pathol 21:1-6. 2008
    ....